Search

Development of 5-Fluorouracil Derivatives as Anticancer Agents

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 4538-4556
Author(s): Xiaoyan Pan, Chen Wang, Fang Wang, Pengfei Li, Zhigang Hu, Yuanyuan Shan, Jie Zhang

Zebrafish Stem Cell Differentiation Stage Factors Suppress Bcl-xL Release and Enhance 5-Fu-Mediated Apoptosis in Colon Cancer Cells

Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 2 Year: 2011 Page: 261-267
Author(s): F. DAnselmi, A. Cucina, P. M. Biava, S. Proietti, P. Coluccia, L. Frati, M. Bizzarri

Journal: Current Pharmaceutical Analysis
Volume: 7 Issue: 1 Year: 2011 Page: 1-11
Author(s): Barbora Hansova, Stanislav Synek, Radka Opatrilova

Synthesis and Biological Evaluation of Licofelone Derivatives as Anticancer and Anti-inflammatory Agents

Journal: Letters in Drug Design & Discovery
Volume: 8 Issue: 1 Year: 2011 Page: 911-917
Author(s): Wukun Liu, Jinpei Zhou, Huibin Zhang, Hai Qian, Jiahan Yin, Kerstin Bensdorf, Ronald Gust

Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies

Journal: Current Molecular Medicine
Volume: 11 Issue: 5 Year: 2011 Page: 365-372
Author(s): L. Apetoh, F. Vegran, S. Ladoire, F. Ghiringhelli

DNA Copy Number Profiles Correlate with Outcome in Colorectal Cancer Patients Treated with Fluoropyrimidine/Antifolate-based Regimens

Journal: Current Drug Metabolism
Volume: 12 Issue: 1 Year: 2011 Page: 956-965
Author(s): Leticia G. Leon, Elisa Giovannetti, Kees Smid, Bart P.P. van Houte, Axel R. Hanauske, Giuseppe Giaccone, Godefridus J. Peters

Pharmacokinetic and Metabolism Determinants of Fluoropyrimidines and Oxaliplatin Activity in Treatment of Colorectal Patients

Journal: Current Drug Metabolism
Volume: 12 Issue: 1 Year: 2011 Page: 918-931
Author(s): Antonio Gnoni, Antonio Russo, Nicola Silvestris, Evaristo Maiello, Angelo Vacca, Ilaria Marech, Gianmauro Numico, Angelo Paradiso, Vito Lorusso, Amalia Azzariti

Alternative Spliced Variants as Biomarkers of Colorectal Cancer

Journal: Current Drug Metabolism
Volume: 12 Issue: 1 Year: 2011 Page: 966-974
Author(s): Qian Yi, Liling Tang

Insulin Decreases Therapeutic Efficacy in Colon Cancer Cell Line HT29 Via the Activation of the PI3K/Akt Pathway

Journal: Current Drug Discovery Technologies
Volume: 8 Issue: 2 Year: 2011 Page: 119-125
Author(s): Jiezhong Chen, Andrew Katsifis, Changhua Hu, Xu-Feng Huang

Advances in Nano Drugs for Cancer Chemotherapy

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 135-146
Author(s): I. Ali, Rahis-Uddin, K. Salim, M. A. Rather, W. A. Wani, A. Haque